Robert V. Baumgartner - Oct 27, 2022 Form 4 Insider Report for BIO-TECHNE Corp (TECH)

Role
Director
Signature
/s/ Brenda S. Furlow as Attorney-in-Fact for Robert V. Baumgartner pursuant to Power of Attorney previously filed.
Stock symbol
TECH
Transactions as of
Oct 27, 2022
Transactions value $
$0
Form type
4
Date filed
10/31/2022, 05:22 PM
Previous filing
May 11, 2022
Next filing
Oct 30, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction TECH Common Stock Award $0 +338 +3.34% $0.00 10.4K Oct 27, 2022 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction TECH Stock Options (Right to Buy) Award $0 +865 $0.00 865 Oct 27, 2022 Common Stock 865 $295.77 Direct F1
holding TECH Stock Options (Right to Buy) 1.51K Oct 27, 2022 Common Stock 1.51K $255.69 Direct
holding TECH Stock Options (Right to Buy) 633 Oct 27, 2022 Common Stock 633 $515.24 Direct
holding TECH Stock Options (Right to Buy) 3.99K Oct 27, 2022 Common Stock 3.99K $101.19 Direct
holding TECH Stock Options (Right to Buy) 3.13K Oct 27, 2022 Common Stock 3.13K $125.05 Direct
holding TECH Stock Options (Right to Buy) 1.9K Oct 27, 2022 Common Stock 1.9K $179.84 Direct
holding TECH Stock Options (Right to Buy) 2.01K Oct 27, 2022 Common Stock 2.01K $201.64 Direct
holding TECH Stock Options (Right to Buy) 4K Oct 27, 2022 Common Stock 4K $91.78 Direct
holding TECH Stock Options (Right to Buy) 4.26K Oct 27, 2022 Common Stock 4.26K $87.34 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The option vests on the earlier of the one year anniversary of the grant date (10/27/2022) or the date of Bio-Techne's 2023 annual meeting of shareholders.